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Abstract 
We have models of commerce in a Web setting: business to business (B2B) and 
business to consumer (B2C). Now scientists commonly use Web based services to 
perform in-silico experiments. Thus we are prompted to ask the question "Are e-
Scientists doing e-Business?". Do the infra-structure and models offered by e-
Commerce support the activities e-Scientists need to perform? In this position paper we 
compare e-Science and e-Business using the discipline of bioinformatics. Such a 
comparison should inform the reuse of existing e-Business technologies in e-Science 
projects. We argue that the individual e-Scientist is now demanding more than the 
simple web interfaces prevalent in consumer e-commerce. Individual e-Scientists need 
to interact in a manner more akin to the B2B model than the B2C style previously used. 
We examine how the infrastructure prevalent in the B2B arena of e-commerce can be 
reused and extended to support the needs of today's e-Scientists. We illustrate this 
argument with reference to the myGrid e-Science middleware project. 
 
1. INTRODUCTION 
In its simplest sense, e-business is the use of Internet technologies to improve and transform key business 
processes. Businesses web-enable core processes to strengthen customer service operations, streamline 
supply chains and reach existing and new customers. This has led to the requirement for a massively 
scalable, reliable and secure electronic foundation which includes reliable and available servers, robust 
software and middleware [1]. It is appealing to think that this infrastructure could be directly used to support 
the emerging field of e-Science. However this approach will only succeed if the e-Business and e-Science 
are sufficiently similar. In this position paper we make a first step to compare current e-Business with e-
Science, and use the e-Science pilot project 
myGrid to illustrate the consequences of the similarities and 
differences. 
E-Science covers a broad range of disciplines but for this paper we will concentrate on the biological domain. 
Biology is a multi-faceted and increasingly multi-disciplinary science. It has already moved to large 
interdisciplinary teams distributed throughout the world working together on specific problems. Much biology 
is based on comparative and speculative reasoning; predicting what might happen based on its relationship 
to "similar" things seen and studied previously. There is substantial use of electronic resources to compare 
new results with the existing body of biological knowledge. Discovery is done by combining and collating 
results obtained from a number of analysis and data resources. These in-silico experiments complement 
experiments in vitro by synthesising new information from available data and generating hypotheses for lab-
based confirmation.  
From the early 1990s web technology has been enthusiastically adopted by the biological community to 
disseminate data and analysis methods. Bioinformaticians can carry out simple, "low volume" in-silico 
experiments by cutting and pasting data between web pages. However, the complexity of potential in-silico 
experiments together with the volumes of data produced by high throughput experimentation is now 
threatening to overwhelm standard web technology. The data are often complex, variable in quality, 
frequently changing and mostly comprised of incomplete data sets. Analysis methods are constantly and 
rapidly evolving. There is a positive feedback cycle. As more resources become available, more in-silico 
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experiments can be done, these generate more resources and knowledge for designing further experiments. 
The key requirements for bioinformaticians are: discovering web-based resources and gaining access to 
them, orchestrating their use of resources in in silico experiments, and maintaining provenance records of 
what has been done. 
The 
myGrid project (http://www.myGrid.org.uk) aims to provide a personalisable collaborative problem-solving 
platform for an individual e-Scientist working in a distributed environment. The application focus is on data-
intensive bioinformatics. The idea is that a scientist can construct long-lived in-silico experiments 
represented as workflows, find and adapt others and publish their own. They can have private personal data 
collections and also pool them, have their own view on public repositories and be able to easily interoperate 
these with their own data or tools. By being better informed as to the provenance and the currency of the 
tools and data directly relevant to them the hope is to improve both the quality of information in repositories 
and the way repositories or tools are used. The 
myGrid architecture is based on services, initially 
implemented by Web services but is intended to be delivered as Grid Services [7]. 
2. MODELS OF INTERACTION 
E-business interactions can be divided into two broad areas business to business (B2B) and business to 
consumer (B2C). In the B2B case the driving force is on businesses cooperating within a value chain each 
business concentrates on its core competencies and outsources other tasks to its partners. Partnerships 
involve complex negotiation, and coordination of business processes. In the B2C case the driving force is the 
individual consumer who accesses one business' services through a simple static interface such as a web 
browser. The most widely used example is ordering a book on from amazon.com. Typically consumers are 
interested in results; they expect providers or brokers to orchestrate services and present them with a 
straight-forward interface. If a service does not satisfy their requirements they will seek another service 
provider. 
In a commercial setting, businesses will typically interact according to a well-defined process for outsourcing, 
which is predominately applicable to B2B interactions. UN/CEFACT defines the steps of outsourcing to be 
implementation, discovery, design and runtime [2]. Implementation is the provision and publication of a 
service's particular e-Business capabilities. Discovery refers to the process by which a potential business 
partner can discover the service provider and the capabilities of their service. Design is the stage of defining 
the process by which one or more services are orchestrated to fulfil an overall objective. Finally, runtime 
refers to the execution of the services. The ebXML community defines a similar set of steps, including 
process definition; partner discovery; partner sign-up; process execution; and process management [3]. The 
implementation of the outsourcing process can be readily mapped onto various underlying technologies, for 
example by using the 'publish', 'find', 'bind' model of Web Services [4] accompanied by a suitable Web 
Service orchestration language such as BPEL4WS [5] or WSFL [6].  
Although currently not well characterised, e-Science interactions can be divided into two distinct types 
analogous to e-Business: enterprise e-Science and personal e-Science.  
Enterprise e-Science occurs between organisations or institutions of scientists and is analogous to B2B. 
Groups cooperate in order to pool limited resources. As in business, partnerships increasingly involve 
complex negotiation concerning intellectual property rights. For example, any submission of a nucleotide 
sequence to either the EMBL, Genbank or DDBJ databanks is transferred between the other resources. The 
three organisations have negotiated a collaboration to ensure that all three resources contain the same data. 
Personal e-Science needs support beyond a simple B2C model. The individual scientist is not a long term 
partner keen to spend time and effort negotiating contract agreements. However the scientist is interested in 
maintaining control of the orchestration of distributed services into in silico experiments. They can not be 
considered an outsider with little interest in how the service works as in the classic B2C scenario. They must 
act as an active if short-lived business partner with rights to orchestrate the surrounding services.  
3. DISCOVERY AND NEGOTIATION 
One of the characteristics of e-Science is that scientists are very interested in the discovery and selection of 
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services. They need to know the most applicable services so that their results are valid within their 
community, so their outlook is that of a strong business partner rather than a casual consumer. As more 
services become available, there must be ways to discover those that are relevant in the context of a specific 
in-silico experiment. 
Within B2B, the process of service discovery is in two phases. The first is a rough identification of potential 
business pertners. This requires service providers to advertise themselves sufficiently as a candidate with 
the right service capability and distinguish themselves from competitors. The provider needs to advertise just 
enough to hook a potential partner. The yellow and white pages of UDDI [8], for example, give rather coarse-
grained and weak descriptions of service function and quality of service. The second phase is a one-one 
negotiation of service level agreements. In contrast to the shop-front of the first phase, this is conducted 
behind closed doors. Detailed service capabilities are requested and traded under non-disclosure contractual 
obligations. 
In personal e-Science an individual has little scope to force the modification of a service in terms of 
functionality or performance. What you see is what you get. Negotiation is replaced by a much more detailed 
discovery process in which the exact requirements are certain to be met. Thus, the service description must 
be rich enough to make a decision about whether it will fulfil the task. This discovery mechanism is not a 
one-off exercise during the design of an in-silico experiment. Often the life of an experimental design may 
outlive the availability of a service, or a more appropriate service may be published in the interim. It is 
therefore desirable to describe the functionality required and defer actual selection of a service until the 
experiment is run.  
It is also important that the service discovery mechanisms are open and extendable. New more specialised 
data sets and more sophisticated computational methods will continue to become available and will need to 
be described. These will need to be discovered as easily as those available today. The consequences for 
myGrid are: 
1.  To extend the description of a service beyond a brief advertisement. A controlled vocabulary is used 
to describe the functionality of the service in terms of its inputs, outputs, resources used and overall 
goal [9]. DAML-S [10] is an ontology based schema with which to describe a web service in the 
business setting. It has to be extended beyond its business roots to cover the relevant functional 
attributes on which the scientist could base their choice. For example, the algorithm used, the name 
of the application used to implement the service, and the generic nature of the task performed. 
2. 
myGrid's description of services needs to deal with the rapidly evolving nature of bioinformatics 
services. The ontology of services must be open and extensible. The autonomous service providers 
must have access to a vocabulary and a formal grammar that enables them to independently 
construct novel service descriptions. 
Although it is not possible for the scientist to modify a service, general services such as those that provide 
access to databases, do allow complex configuration to perform a specific task. Translating from the goals of 
the scientist to the appropriate services is not just about selecting between equivalent services based on cost 
or reliability. Geodise [11] (http://www.geodise.org) is another e-Science pilot project, which as part of its 
remit, is examining the explicit knowledge required to configure complex computational services.  
4. ORCHESTRATION USING WORKFLOW 
Capturing in-silico experiments as a reusable process that can be defined, published and repeatedly 
executed is essential when sharing scientific best practice. In bioinformatics, processes are reusable at many 
levels.  
At a basic level, a process might capture how to use a programming API of a remote application, for example 
proving input data, executing and then retrieving the results for a protein similarity search. This process is 
analogous to simple B2C or B2B processes such as use of an on-line flight reservation service.  
Basic bioinformatics processes can be combined in order to orchestrate a set of applications to perform a 
higher-level function, for example the combination of protein similarity searching with a protein structure 
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database to provide protein structure prediction. These processes are analogous to aggregate or brokered 
B2C processes such as coordination of flight, hotel and excursion booking to form a holiday package. 
However in e-Science the consumer wants control over the coordination.  
Finally, in bioinformatics the semantics of service orchestration can be abstracted away from the syntactic 
details of data exchange, data transformation and specific application invocation, to create reusable 
processes that can be customised to individual scientists and service providers. For example, general 
bioinformatics processes include structure prediction, literature knowledge extraction, and annotation 
curation in databases. These are examples of e-business patterns, as identified by IBM [12] in this case 
'extended enterprise', 'information aggregation', and 'collaboration' respectively.  
myGrid aims to support personal interaction with workflow at these multiple levels. Users must be able to 
create novel workflows and specialise workflow templates held in a library. Workflows must be described as 
resources in their own right to enable their discovery. 
The scientist must be able to control the enactment or delivery of a set of services. The speculative nature of 
the task, requires the scientist to monitor the state of the process, and possibly steer it in the light of 
intermediate results. An enactment engine has been built by the 
myGrid partner IT Innovation (http://www.it-
innovation.soton.ac.uk), which interprets workflows specified in WSFL, and allows interaction with the user 
during the enactment process. In current 
myGrid workflows this allows certain steps to be under-specified; for 
example denoting the functional class of service to be used rather than a specific instance. The user can 
then be asked to choose which of the services available at that time should be used.  
5. PROVENANCE 
Although the physical confederation of services may be transient, the results are not. In science as in many 
fields the mechanism by which the results are obtained can be of more importance than the results 
themselves. There needs to be an explicit record of the origin of results which resources were used, when, 
what parameters were supplied etc. This is essential evidence for assessing whether an in silico experiment 
needs to be re- run in the light of new evidence, such as updated resources. A provenance record is also 
essential if for legal reasons an e-scientist needs to prove that a given result was obtained on a specific date, 
using a particular set of resources available at that time. 
Provenance of data is analogous to traceability of raw materials in business. "...The capability to follow the 
path of a specified unit of a product through the supply chain as it moves between organisations. Products 
are traced for purposes such as product recall and investigating complaints.." [13]. A key mechanism for 
achieving traceability is a unique identifier for all items in the supply chain and the European Article 
Numbering (EAN) provides just such a mechanism. In 
myGrid we aim to identify all input data, intermediate 
and final results together with the process used to create the results. 
myGrid is monitoring the development of 
the Life Sciences Identifier (LSID). A LSID is a standard mechanism in development by I3C 
(http://www.i3c.org) for identifying biologically significant resources and may become the bioinformatics 
equivalent of the EAN.  
It is equally important to record the process by which results are obtained. Business processes often include 
secure and verifiable business transaction semantics [14]. These are directly applicable to scientific 
processes since they provide a mechanism for provenance to be established. Security techniques allow a 
verifiable audit trail to be created to establish what was done at the time of an in-silico experiment in terms of 
who was involved, what applications were executed, what data was used, and most importantly what 
process was followed. Whilst there is the possibility to use this for legal purposes, one of the key values is to 
enable in-silico experiments to be re-run if new data or services become available and then results 
meaningfully compared with historical analysis.  
6. DISCUSSION 
We have asked ourselves the question "Do bioinformaticians perform e-Business?". Simply, the answer is 
"yes". E-Scientists use Web based services in a range of activities, from a single step analysis akin to the 
B2C model, up to the orchestration of multiple services like that of the B2B model. 
myGrid has thus been able 
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to reuse e-Business technologies such as UDDI registries, workflow languages and enactment systems to 
support personal e-Science.  
Of course, the reality is a little more complex. We have correlates of the B2B and the B2C models, but 
modern bioinformatics needs an intermediate level of interaction. In this style, an individual e-Scientist needs 
to transiently behave in a B2B model, orchestrating autonomous, distributed, heterogeneous services to 
analyse, discover or create new data. Users must have access to detailed service descriptions to inform 
unilateral partnership formation and orchestration. They must be supported in the interaction with workflow 
representations and in the recording of experiments performed.  
For such an infrastructure, a far more explicit semantic representation of service capabilities and interaction 
is needed. The encoded knowledge must support a model of interaction by which a middleware broker 
allows access to the full functionality of a set of dynamically orchestrated services, while shielding the 
scientist from the full complexity of implementing that orchestration. 
myGrid has begun to build the additional 
middleware components and explicit knowledge necessary to support the personal e-Scientist and will 
deliver these to the community.  
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